Docoh
Loading...

ESPR Esperion Therapeutics

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Wednesday
19 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Wednesday's morning trading, 400 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
14 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Friday's session, 445 companies made new 52-week lows.
Credit Suisse Maintains Neutral on Esperion Therapeutics, Lowers Price Target to $6
14 Jan 22
News, Price Target, Analyst Ratings
Credit Suisse analyst Judah Frommer maintains Esperion Therapeutics (NASDAQ:ESPR) with a Neutral and lowers the price target from $8 to $6.
Esperion Sees Q4 2021 Product Revenue $12M-$12.5M
11 Jan 22
News, Guidance
Esperion (NASDAQ:ESPR) today announced preliminary, unaudited fourth-quarter 2021 financial results and reiterated full-year 2022 operating expense guidance. "2021 was a transitional year for
Stocks That Hit 52-Week Lows On Friday
7 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Before 10 am on Friday, 110 companies set new 52-week lows.
10 Biggest Price Target Changes For Thursday
9 Dec 21
Price Target, Intraday Update, Analyst Ratings
SVB Leerink boosted the price target on Edwards Lifesciences Corporation (NYSE: EW) from $130 to $135. Edwards Lifesciences shares rose 1% to trade at $120.68 on Thursday.
Needham Maintains Buy on Esperion Therapeutics, Lowers Price Target to $12
9 Dec 21
News, Price Target, Analyst Ratings
Needham analyst Serge Belanger maintains Esperion Therapeutics (NASDAQ:ESPR) with a Buy and lowers the price target from $20 to $12.
10 Biggest Price Target Changes For Monday
6 Dec 21
Price Target, Small Cap, Pre-Market Outlook, Analyst Ratings
Cowen & Co. raised the price target on The Boston Beer Company, Inc. (NYSE: SAM) from $400 to $500. Boston Beer shares rose 1% to $465.20 in pre-market trading.
Goldman Sachs Maintains Sell on Esperion Therapeutics, Lowers Price Target to $5
6 Dec 21
News, Price Target, Analyst Ratings
Goldman Sachs maintains Esperion Therapeutics (NASDAQ:ESPR) with a Sell and lowers the price target from $8 to $5.
Credit Suisse Maintains Neutral on Esperion Therapeutics, Lowers Price Target to $8
6 Dec 21
News, Price Target, Analyst Ratings
Credit Suisse analyst Judah Frommer maintains Esperion Therapeutics (NASDAQ:ESPR) with a Neutral and lowers the price target from $11 to $8.
58 Biggest Movers From Friday
6 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30.
Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb
3 Dec 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Friday, the Dow traded down 0.37% to 34,512.05 while the NASDAQ fell 2.28% to 15,029.99. The S&P also fell, dropping 1.13% to 4,525.40.
12 Health Care Stocks Moving In Friday's Intraday Session
3 Dec 21
Intraday Update, Markets, Movers
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings
3 Dec 21
Earnings, News, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Friday, the Dow traded down 0.77% to 34,373.98 while the NASDAQ fell 2.8% to 14,950.19. The S&P also fell, dropping 1.52% to 4,507.37.
41 Stocks Moving In Friday's Mid-Day Session
3 Dec 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers IO Biotech, Inc. (NASDAQ: IOBT) jumped 42% to $11.74. The company, last month, priced its IPO at $14 per share.
Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast
3 Dec 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Friday, the Dow traded down 0.31% to 34,532.63 while the NASDAQ fell 1.44% to 15,160.41. The S&P also fell, dropping 0.60% to 4,549.65.
Esperion Shares Fall After $225M Capital Raise Via Equity
3 Dec 21
Biotech, News, Health Care, Financing, Offerings, Movers, Trading Ideas, General
Esperion Therapeutics Inc (NASDAQ: ESPR) priced its previously announced underwritten public offering of 32.14 million shares and short-term warrants to purchase up to 32.14 million shares
12 Health Care Stocks Moving In Friday's Pre-Market Session
3 Dec 21
Pre-Market Outlook, Markets, Movers
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
3 Dec 21
Biotech, News, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
20 Stocks Moving in Friday's Pre-Market Session
3 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers BIOLASE, Inc. (NASDAQ: BIOL) rose 27.2% to $0.52 in pre-market trading. Biolase reporte in Form4 filing that President bought 70,000 shares at an average price of $0.45 per share.

Press releases

From Benzinga Pro
Esperion to Participate in Upcoming Virtual J.P. Morgan 40th Annual Healthcare Conference
6 Jan 22
News, Health Care, Press Releases
ANN ARBOR, Mich., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming virtual J.P. Morgan 40th Annual
Esperion Appoints Benjamin O. Looker as General Counsel
4 Jan 22
News, Legal, Press Releases
ANN ARBOR, Mich., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR), today announced the appointment of Benjamin O. Looker as general counsel as of January 1, 2022. Mr. Looker will serve as a member of the
Esperion Announces Closing of $225 Million Public Offering
7 Dec 21
News, IPOs, Press Releases
ANN ARBOR, Mich., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) ("Esperion" or the "Company"), today announced the closing of its previously announced underwritten public offering of 32,142,858 shares of
Thinking about buying stock in DiDi Global, New Oriental Education, Longeveron, Carnival Corp, or Esperion Therapeutics?
3 Dec 21
Opinion, Press Releases
NEW YORK, Dec. 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DIDI, EDU, LGVN, CCL, and ESPR.
Esperion Announces Pricing of $225 Million Public Offering
2 Dec 21
Markets, Press Releases
ANN ARBOR, Mich., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) ("Esperion" or the "Company"), today announced the pricing of its previously announced underwritten public offering of 32,142,858 shares of its
Esperion Announces Proposed Public Offering
2 Dec 21
Markets, Press Releases
ANN ARBOR, Mich., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) ("Esperion" or the "Company"), today announced that it intends to offer and sell, subject to market and other conditions, shares of its common
Esperion Presents Important New Science Highlighting Potential Benefits of NEXLETOL® (bempedoic acid) Tablets at American Heart Association Scientific Sessions 2021
12 Nov 21
News, Health Care, Press Releases
- Analysis of pooled Phase 3 data showed that NEXLETOL [bempedoic acid (BA)] alone lowered LDL-C levels comparable to that of a moderate- or high-intensity statin (≥ 30%) in nearly 1 out of 3 of patients - - In patients
Esperion to Present Key Science at the American Heart Association Scientific Sessions 2021
1 Nov 21
News, Press Releases
ANN ARBOR, Mich., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced the presentation of three abstracts at the American Heart Association (AHA) Scientific Sessions 2021 taking place on November
Esperion Announces the Appointment of Seth H.Z. Fischer to its Board of Directors
1 Nov 21
News, Management, Press Releases
ANN ARBOR, Mich., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced the appointment of Seth H.Z. Fischer as a Class III director, with a term expiring at the 2022 meeting of stockholders.
Esperion to Participate in Upcoming Virtual Investor Conference
27 Oct 21
News, Press Releases
ANN ARBOR, Mich., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that members of Esperion's management team will participate in the upcoming Credit Suisse 30th Annual Healthcare Conference.
ESPERION Announces Agreement to Exchange $15 Million in Principal Amount of its 4.00% Convertible Senior Subordinated Notes due 2025 for Common Stock
25 Oct 21
Press Releases
ANN ARBOR, Mich., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that it has entered into a privately negotiated exchange agreement with two co-managed holders (the "Holders") of its 4.00%